Social determinants and hepatitis C among people who inject drugs in Kermanshah, Iran: Socioeconomic status, homelessness, and sufficient syringe coverage

被引:20
|
作者
Rezaei, Fatemeh [1 ]
Noroozi, Alireza [2 ,3 ]
Armoon, Bahram [4 ]
Farhoudian, Ali [5 ]
Massah, Omid [5 ]
Sharifi, Hamid [6 ,7 ]
Ahounbar, Elaheh [8 ]
Khodadost, Mahmoud [9 ,10 ]
Mohammadi, Farahnaz [11 ]
Barkhordar, Nasrin [12 ]
Mansourian, Morteza [13 ]
Noroozi, Mehdi [5 ]
机构
[1] Jahrom Univ Med Sci, Dept Epidemiol & Biostat, Fars, Iran
[2] Tehran Univ Med Sci, SATiM, Tehran, Iran
[3] Minist Hlth & Med Educ MoHME, SAPTO, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Dept Epidemiol, Tehran, Iran
[5] Univ Social Welf & Rehabil Sci, Subst Abuse & Dependence Res Ctr, Student Blvd, Tehran, Iran
[6] Kerman Univ Med Sci, HIV STI Surveillance Res Ctr, Kerman, Iran
[7] Kerman Univ Med Sci, WHO Collaborating Ctr HIV Surveillance, Inst Futures Studies Hlth, Kerman, Iran
[8] Univ Social Welf & Rehabil Sci, Psychosis Res Ctr, Tehran, Iran
[9] Baqiyatallah Univ Med Sci, Gastroenterol & Liver Dis Res Ctr, Tehran, Iran
[10] Iran Univ Med Sci, Fac Hlth, Dept Epidemiol, Tehran, Iran
[11] Univ Social Welf & Rehabil Sci, Social Determinants Hlth Res Ctr, Tehran, Iran
[12] Kermanshah Univ Med Sci, Mental Hlth, Kermanshah, Iran
[13] Iran Univ Med Sci, Sch Hlth, Dept Hlth Educ & Promot, Tehran, Iran
关键词
High-risk injection behaviors; needle and syringe programs; people who inject drugs; VIRUS-INFECTION; EXCHANGE PROGRAMS; USERS; HIV; PREVALENCE; NEEDLE; RISK; PREVENTION; CALIFORNIA; BEHAVIOR;
D O I
10.1080/14659891.2016.1245793
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: It has been estimated that 2-4 million people in developing countries possess HCV infection driven by unsafe injection drug use each year that is extending to other population. High-risk injection behaviors are the leading cause of HCV infections among PWIDs. The purpose of this study was to survey prevalence of HCV and risk factors associated with HCV among injecting drug users. Methods: This cross-sectional study was carried out on 410 injection drug users in Kermanshah that were recruited through peer-referral and convenience sampling from two Drop-In Centers (DICs). Data were collected using structured information form, and data analysis was done with descriptive and logistic regression. Results: A total of 410 men who injected drugs participated in this study. The mean age +/- standard deviation (SD) was 33.2 +/- 7.3 (range 19-58) years, Overall, the prevalence of HCV infections was 42% (95% CI: 23.7-52.5). Trend test showed clear trends for living place, income, age of first injecting drug, age at first drug use across the two groups (P-value < 0.05), but there was no significant trend for marital status, education level, or age (P-value > 0.05). Conclusion: Developing the needle and syringe programs could reduce unsafe injection rate among PWIDs. Therefore, the more accurate and better coverage of NSP programs in PWID, the more reduce in needle sharing rate and HCV infection.
引用
收藏
页码:474 / 478
页数:5
相关论文
共 50 条
  • [31] Is hepatitis C virus (HCV) elimination achievable among people who inject drugs in Tijuana, Mexico? A modeling analysis
    Marquez, Lara K.
    Cepeda, Javier A.
    Borquez, Annick
    Strathdee, Steffanie A.
    Gonzalez-Zuniga, Patricia E.
    Fleiz, Clara
    Rafful, Claudia
    Garfein, Richard S.
    Kiene, Susan M.
    Brodine, Stephanie
    Martin, Natasha K.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2021, 88
  • [32] Syringe disposal among people who inject drugs in Los Angeles: The role of sterile syringe source
    Quinn, Brendan
    Chu, Daniel
    Wenger, Lynn
    Bluthenthal, Ricky N.
    Kral, Alex H.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2014, 25 (05) : 905 - 910
  • [33] Hepatitis C among people who inject drugs in Tbilisi, Georgia: An urgent need for prevention and treatment
    Bouscaillou, Julie
    Champagnat, Julie
    Luhmann, Niklas
    Avril, Elisabeth
    Inaridze, Ina
    Miollany, Veronique
    Labartkava, Koka
    Kirtadze, Irma
    Butsashvili, Maia
    Kamkamidze, George
    Pataut, Dominique
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2014, 25 (05) : 871 - 878
  • [34] Hepatitis C cascade of care among people who inject drugs in Vancouver, Canada
    Young, Samantha
    Wood, Evan
    Milloy, M. -J.
    DeBeck, Kora
    Dobrer, Sabina
    Nosova, Ekaterina
    Kerr, Thomas
    Hayashi, Kanna
    SUBSTANCE ABUSE, 2018, 39 (04) : 461 - 468
  • [35] Modeling the Impacts of Prevention and Treatment Interventions on Hepatitis C Among People Who Inject Drugs in China
    Fang, Kailu
    Wang, Hong-liang
    Lin, Yushi
    Li, Shuwen
    Wu, Jie
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (04) : 1043 - 1055
  • [36] Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study
    Malme, Kristian Braathen
    Ulstein, Kjersti
    Finbraten, Ane-Kristine
    Wusthoff, Linda Elise Couessurel
    Kielland, Knut Boe
    Hauge, Joakim
    Dalgard, Olav
    Midgard, Havard
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2023, 116
  • [37] Modeling the spread of hepatitis C virus amongst people who inject drugs
    Greenhalgh, David
    Al-Rashidi, Nader
    ENGINEERING REPORTS, 2022, 4 (10)
  • [38] Comparing profile of people who inject drugs (PWID) accessing different types of needle and syringe programs or secondary distribution in Kermanshah, Iran
    Noroozi, Alireza
    Mirzazadeh, Ali
    Hajebi, Ahmad
    Farhoudian, Ali
    Sharifi, Hamid
    Higgs, Peter
    Noroozi, Mehdi
    JOURNAL OF SUBSTANCE USE, 2017, 22 (03) : 304 - 309
  • [39] High dead-space syringe use among people who inject drugs in Tijuana, Mexico
    Rafful, Claudia
    Zule, William
    Gonzalez-Zuniga, Patricia E.
    Werb, Dan
    Elena Medina-Mora, Maria
    Magis-Rodriguez, Carlos
    Strathdee, Steffanie A.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2015, 41 (03) : 220 - 225
  • [40] Dynamic modeling of hepatitis C transmission among people who inject drugs
    Stocks, Theresa
    Martin, Leah J.
    Kuhlmann-Berenzon, Sharon
    Britton, Tom
    EPIDEMICS, 2020, 30